Example: air traffic controller
PRODUCT INFORMATION - Medicines
Version: pfpprist21217 Supersedes: pfpprist11217 Page 1 of 18 PRODUCT INFORMATION PRISTIQ desvenlafaxine (as succinate) NAME OF THE MEDICINE PRISTIQ Desvenlafaxine (as succinate) 50 mg, 100 …
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
DEPOT PREFILLED DUAL-CHAMBER SYRINGE (PDS) …
www.medicines.org.auLucrin Depot Prefilled Dual-Chamber Syringe (PDS) Injection Version 13 12 May 2015 Page 2 of 18 Lucrin Depot 3-Month PDS Injection is available as sterile lyophilised microspheres, which, when
ELEVA - Medicines
www.medicines.org.auELEVA – PRODUCT INFORMATION 3 During prolonged maintenance therapy for any indication, dosage should be kept at the lowest effective level.
Aratac - Medicines
www.medicines.org.auAratac – Product Information 4 case amiodarone should be withdrawn. Recovery usually occurs within a few months following withdrawal of treatment; clinical recovery precedes the normalisation of thyroid function tests.
Deralin - Medicines
www.medicines.org.auDeralin – Product Information 2 The possible mechanism of the antianginal activity of propranolol hydrochloride appears to be due to a reduction in left ventricular work and oxygen utilisation resulting from inhibition of cardiac sympathetic nerve
AUSTRALIAN PRODUCT INFORMATION ... - …
www.medicines.org.auCABOMETYX Product Information V1.0 4 Safety and efficacy of cabozantinib has not been evaluated in patients with NMYHA Class 3 or 4 Heart Failure and patients with endobronchial manifestations of RCC.
Product Information Zyrtec - Medicines
www.medicines.org.auZyrtec PI Page 1 of 8 Australia J&J Pacific 3rd April 2014 1 of 8 Product Information Zyrtec NAME OF THE MEDICINE Cetirizine hydrochloride DESCRIPTION Cetirizine hydrochloride is an orally active, H
PRODUCT INFORMATION Axit - Medicines
www.medicines.org.auAxit – Product Information 3 Geriatric. The recommended dosage regimen is the same as for adults. Increases should be monitored carefully (see DOSAGE AND ADMINISTRATION).
PRODUCT INFORMATION CLOFEN - Medicines
www.medicines.org.auCLOFEN – PRODUCT INFORMATION 2 Pharmacokinetics Absorption Baclofen is rapidly and completely absorbed from the gastrointestinal tract. Maximum concentrations of …
Humira Pen - Medicines
www.medicines.org.auHUMIRA 40MG/0.8ML PEN 16 APRIL 2018 VERSION 24 2 pan-uveitis, an inflammatory disease of the uveal tract of the eye. Humira is used in adults who have not
AUSTRALIAN PRODUCT INFORMATION PANADOL …
www.medicines.org.au4 PANADOL CHILDREN 1 to 5 YEARS COLOURFREE SUSPENSION AGE AVERAGE WEIGHT DOSE 1 – 2 years 10 - 12 kg 6 - 8 mL 2 – 3 years 12 - 14 kg 8 - 9 mL
Related documents
HAMILTON DEPRESSION RATING SCALE (HAM-D) …
www.assessmentpsychology.comHAMILTON DEPRESSION RATING SCALE (HAM-D) Instructions for the Clinician: The Hamilton Depression Rating Scale (HAM-D) has proven useful for many years as
HAMILTON DEPRESSIONSSKALA (HAM-D)
www.videnscenterfordemens.dkHAMILTON DEPRESSIONSSKALA (HAM-D) REFERENCER Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56 …
Hamilton Rating Scale for Depression (17-items)
www.outcometracker.orgCitation: Hamilton M: A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 23:56-62, 1960
HAMILTON DEPRESSION R S (HAM-D)
www.assessmentpsychology.comHAMILTON DEPRESSION RATING SCALE (HAM-D) (To be administered by a health care professional) Patient Name _____ Today’s Date _____ The HAM-D is designed to rate the severity of depression in patients.
CONSUMER MEDICINE INFORMATION - Medsafe
www.medsafe.govt.nzLexapro Data Sheet 31 July2014 v2 Page 3of 20 Clinical Trials Major Depression Two fixed-dose studies and one flexible-dose study have shown escitalopram in …
Effexor (venlafaxine hydrochloride) Tablets …
www.accessdata.fda.govClinical Global Impression-Severity of Illness rating. Doses from 75 to 225 mg/day were superior to placebo in outpatient studies and a mean …
Transcranial Magnetic Stimulation - Magellan …
magellanprovider.comTranscranial Magnetic Stimulation Criteria for Privileging 1. Treating physician must have completed a psychiatry residency program accredited by the Accreditation Council for Graduate Medical Education (ACGME)